RVMD Revolution Medicines, Inc.
Price Chart
Executive Summary
Anthony Mancini, an insider at Revolution Medicines, exercised options for 74,900 shares and sold 1,800 shares on the open market for $167,801. The majority of the transaction value comes from non-cash derivative exercises, with only a small portion representing actual open-market selling.
Key Financial Metrics
Actionable Insight
The activity is consistent with routine option exercise and minimal selling; not a signal of distress or strong conviction. Monitor for additional selling in coming days.
Key Facts
- Anthony Mancini exercised options for 74,900 shares in two tranches of 37,450 shares each, one at $0 and one at $33.62 per share, resulting in a total cost of $1,259,069.
- Mancini sold 1,800 shares on the open market for $167,801 at an average price of $93.223.
- The total open-market sale represents approximately 0.0009% of Revolution Medicines' $18.7B market cap, well below the 0.1% threshold for materiality.
Financial Impact
$167,801 in open-market sales and $1.26M in derivative exercises (non-cash)
Risk Factors
- Potential for minor dilution from newly exercised shares, though not material given company size.
- Perception risk if more insiders follow with similar transactions.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-RVMD-1774569874022 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 31, 2026
9d ago
|
Press Release
| $163.68 $149.23 | ▼ −8.83% | ▼ −6.08% | $149.55 (−8.63%) |
|
May 6, 2026
4w ago
|
Press Release
| $142.51 $149.94 | ▲ +5.21% | ▲ +3.71% | $149.55 (+4.94%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $141.50 $140.80 | ▼ −0.49% | ▼ −0.55% | $149.55 (+5.69%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $141.50 $140.80 | ▼ −0.49% | ▼ −0.55% | $149.55 (+5.69%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $148.90 $144.83 | ▼ −2.73% | ▼ −3.82% | $149.55 (+0.44%) |
|
Apr 19, 2026
7w ago
|
Press Release
| $146.23 $131.67 | ▼ −9.96% | ▼ −10.87% | $149.55 (+2.27%) |
|
Apr 17, 2026
7w ago
|
Press Release
| $146.23 $131.67 | ▲ +9.96% | ▲ +10.87% | $149.55 (−2.27%) |
|
Apr 15, 2026
7w ago
|
Press Release
| $152.54 $141.50 | ▲ +7.24% | ▲ +8.88% | $149.55 (+1.96%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $147.01 $148.90 | ▼ −1.29% | ▲ +0.11% | $149.55 (−1.73%) |
|
Mar 19, 2026
11w ago
|
Insider Cluster
| $99.29 $93.21 | ▼ −6.12% | ▼ −3.91% | $149.55 (+50.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access